Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
8 "Macrophages"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Original Articles
Persistent Adipose Inflammation Despite Metabolic Recovery Reveals Tissue-Specific Immunomodulation by Tirzepatide
Mihye Seo, Maria Averia, Vivi Julietta, Shindy Soedono, Esther Jin Joo, Ellen Budiono, Minjoon Lee, Min-Kyu Kim, Yongsung Hwang, Hyeong Kyu Park, Kyoil Suh, Kae Won Cho
Received November 3, 2025  Accepted January 15, 2026  Published online May 15, 2026  
DOI: https://doi.org/10.3803/EnM.2025.2766    [Epub ahead of print]
  • 3,637 View
  • 157 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Obesity is characterized by chronic inflammation and fibrosis of adipose tissue; however, the extent to which these pathological features persist during pharmacologically induced weight loss remains poorly understood. This study investigated the effects of tirzepatide, a dual agonist of the glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors, on adipose tissue inflammation and fibrosis in obese mice.
Methods
Diet-induced obesity was treated with tirzepatide or vehicle for 25 days. Metabolic parameters, tissue inflammation, fibrosis, and macrophage activation were assessed using histology, flow cytometry, gene expression analyses, and immunoblotting. In vitro experiments were conducted to compare the effects of tirzepatide on classically activated and metabolically activated macrophages.
Results
Tirzepatide significantly reduced body weight and adiposity, increased energy expenditure, and upregulated thermogenic and mitochondrial proteins in brown adipose tissue. Hyperglycemia and glucose intolerance were normalized. However, adipose tissue inflammation and fibrosis persisted despite weight loss, as evidenced by sustained immune cell infiltration, collagen deposition, and activation of Yes-associated protein (YAP)/transcriptional coactivator with PDZ-binding motif (TAZ) signaling. In contrast, hepatic inflammation and fibrosis were substantially improved. Mechanistically, tirzepatide suppressed inflammatory gene expression in classically activated macrophages but not in metabolically activated macrophages, suggesting that the local metabolic context determines tissue responsiveness to its anti-inflammatory actions.
Conclusion
Tirzepatide exerts distinct tissue-specific effects on inflammation and fibrosis during weight loss, ameliorating hepatic pathology while sparing adipose tissue inflammation. These findings identify metabolically activated macrophages as potential determinants of tissue-specific inflammatory persistence and underscore the need for therapeutic strategies that target macrophage activation and fibrotic remodeling to achieve durable metabolic benefits during pharmacological weight loss.
Close layer
YTHDF1-Mediated m6A Modification of lncRNA OIP5-AS1 Exacerbates Macrophage Metabolic Dysfunction in Diabetes Mellitus with Coronary Artery Disease
Hongjie Wang, Luyao Li, Zhen Zhen, Zheqi Zhang, Ya Su, Bo Li
Received July 21, 2025  Accepted December 15, 2025  Published online May 7, 2026  
DOI: https://doi.org/10.3803/EnM.2025.2566    [Epub ahead of print]
  • 976 View
  • 19 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Diabetes mellitus (DM) with coronary artery disease (CAD), referred to as DM-CAD, is a prevalent endocrine-metabolic condition characterized by macrophage-driven inflammation and metabolic dysregulation. This study aims to investigate the role of YTH N6-methyladenosine RNA binding protein F1 (YTHDF1)-mediated N6-methyladenosine (m6A) modification in stabilizing the long non-coding RNA (lncRNA) Opa interacting protein 5 antisense RNA 1 (OIP5-AS1) and to determine its impact on macrophage metabolic dysfunction in DM-CAD.
Methods
Single-cell RNA sequencing and bulk RNA sequencing were performed using DM-CAD mouse models, with downstream analyses conducted using Seurat, CellChat, least absolute shrinkage and selection operator (LASSO) regression, and random forest algorithms. Experimental validation included RNA immunoprecipitation followed by quantitative polymerase chain reaction, actinomycin D-based RNA stability assays, and 2-deoxyglucose (2-DG) interventions in THP-1–derived macrophages, alongside metabolomic profiling and reactive oxygen species (ROS) measurements.
Results
Increased macrophage-endothelial cell coupling was observed in DM-CAD, with both OIP5-AS1 and YTHDF1 significantly upregulated and closely associated with glycolytic metabolic pathways. YTHDF1-mediated m6A modification stabilized OIP5-AS1, thereby promoting glycolysis, foam cell formation, ROS production, plaque development, and the upregulation of proinflammatory cytokines, collectively exacerbating atherosclerosis. Notably, treatment with 2-DG markedly reversed these pathological phenotypes.
Conclusion
This study identifies the YTHDF1–m6A–OIP5-AS1 axis as a critical regulator of macrophage metabolic dysfunction in DM-CAD, thereby providing an epigenetic framework for understanding disease progression. Targeting this regulatory pathway may attenuate metabolic inflammation and represents a promising therapeutic strategy for endocrine-related cardiovascular complications.
Close layer
Diabetes, Obesity and Metabolism
The Effects of Irisin on the Interaction between Hepatic Stellate Cell and Macrophage in Liver Fibrosis
Dinh Vinh Do, So Young Park, Giang Thi Nguyen, Dae Hee Choi, Eun-Hee Cho
Endocrinol Metab. 2022;37(4):620-629.   Published online July 22, 2022
DOI: https://doi.org/10.3803/EnM.2022.1412
  • 11,421 View
  • 248 Download
  • 15 Web of Science
  • 13 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Hepatic stellate cells (HSCs) are the central players interacting with multiple cell types in liver fibrosis. The crosstalk between HSCs and macrophages has recently become clearer. Irisin, an exercise-responsive myokine, was known to have a potentially protective role in liver and renal fibrosis, especially in connection with stellate cells. This study investigated the effects of irisin on the interaction between HSCs and macrophages.
Methods
Tamm-Horsfall protein-1 (THP-1) human monocytes were differentiated into macrophages, polarized into the inflammatory M1 phenotype with lipopolysaccharide. Lieming Xu-2 (LX-2) cells, human HSCs, were treated with conditioned media (CM) from M1 macrophages, with or without recombinant irisin. HSCs responses to CM from M1 macrophages were evaluated regarding activation, proliferation, wound healing, trans-well migration, contractility, and related signaling pathway.
Results
CM from M1 macrophages significantly promoted HSC proliferation, wound healing, transwell migration, and contractility, but not activation of HSCs. Irisin co-treatment attenuated these responses of HSCs to CM. However, CM and irisin treatment did not induce any changes in HSC activation. Further, irisin co-treatment alleviated CM-induced increase of phopho-protein kinase B (pAKT), matrix metalloproteinase-9 (MMP-9), and tissue inhibitor of metalloproteinases-1 (TIMP-1).
Conclusion
These findings suggested that irisin may play a protective role in the pathogenesis of liver fibrosis, especially when working in the crosstalk between HSCs and macrophages.

Citations

Citations to this article as recorded by  
  • Interactions between hepatic stellate cells and immune cells: Implications for liver fibrosis
    Deyu Xie, Yihui Huang, Yitian Yu, Weikai Jin, Xiangting Zhang, Fujun Yu
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2026; 1872(1): 168062.     CrossRef
  • Sepsis: Heterogeneity, Immunopathology, and Advances in Therapeutic Strategies
    Junxing Qu, Peizhi Li, Zhiheng Sun
    The FASEB Journal.2026;[Epub]     CrossRef
  • Pomolic acid alleviates CCl4‑induced liver fibrosis in mice by suppressing β-arrestin 2-mediated pro-fibrotic macrophage polarization
    Xuan Zhu, Yuhan Zhou, Mingyu Ruan, Xuebin Yang, Gang Pei, Jin Tan
    Scientific Reports.2026;[Epub]     CrossRef
  • Loss of immunometabolic adaptability in MASH: gut-derived signals drive macrophage reprogramming and fibrosis
    Yan Li, Yuyuan Hu, Yuan He, Yuhang Yang, Dingwen Xue, Erkui Xue, Jinghan Jia, Wei Zhang, Jinxi Wang
    Frontiers in Immunology.2026;[Epub]     CrossRef
  • Exercise‐Induced Irisin Antagonizes TGFBR2 to Attenuate Islet Fibrosis and Improve Glucose Homeostasis in Type 2 Diabetes
    Qianqian Wang, Xiaohang Wang, Zhensheng Cai, Vladmir Carvalho, Huan Wang, Yang Chen, Zilin Sun, Shanhu Qiu
    The FASEB Journal.2026;[Epub]     CrossRef
  • Letter to the Editor: Improving the reliability of functional capacity testing in liver cirrhosis: A novel assessment direction
    Marwan SM Al-Nimer
    World Journal of Hepatology.2026;[Epub]     CrossRef
  • Irisin and Metastatic Melanoma: Selective Anti-Invasiveness Activity in BRAF Wild-Type Cells
    Simona Serratì, Roberta Zerlotin, Michele Manganelli, Roberta Di Fonte, Manuela Dicarlo, Angela Oranger, Graziana Colaianni, Letizia Porcelli, Amalia Azzariti, Stefania Guida, Maria Grano, Silvia Concetta Colucci, Gabriella Guida
    International Journal of Molecular Sciences.2025; 26(2): 652.     CrossRef
  • Myokine-mediated muscle-organ interactions: Molecular mechanisms and clinical significance
    Jia Yi, Junyang Chen, Xinlei Yao, Zihao Zhao, Xinxin Niu, Xia Li, Jiacheng Sun, Yanan Ji, Tongxin Shang, Leilei Gong, Bingqian Chen, Hualin Sun
    Biochemical Pharmacology.2025; 242: 117326.     CrossRef
  • The potential of flavonoids in hepatic fibrosis: A comprehensive review
    Zhu Wenbo, Han Jianwei, Liu Hua, Tang Lei, Chen Guijuan, Tian Mengfei
    Phytomedicine.2024; 133: 155932.     CrossRef
  • Irisin Attenuates Hepatic Stellate Cell Activation and Liver Fibrosis in Bile Duct Ligation Mice Model and Improves Mitochondrial Dysfunction
    Thuy Linh Lai, So Young Park, Giang Nguyen, Phuc Thi Minh Pham, Seon Mee Kang, Jeana Hong, Jae-Ho Lee, Seung-Soon Im, Dae-Hee Choi, Eun-Hee Cho
    Endocrinology and Metabolism.2024; 39(6): 908.     CrossRef
  • Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis
    Liang Shan, Fengling Wang, Dandan Zhai, Xiangyun Meng, Jianjun Liu, Xiongwen Lv
    Biomedicine & Pharmacotherapy.2023; 161: 114472.     CrossRef
  • Potential role of irisin in digestive system diseases
    Yueming Zhang, Linxian Zhao, Huan Gao, Jinghui Zhai, Yanqing Song
    Biomedicine & Pharmacotherapy.2023; 166: 115347.     CrossRef
  • The effect of sarcopenia and serum myokines on prognosis and survival in cirrhotic patients: a multicenter cross-sectional study
    Salih Boga, Abdullah Emre Yildirim, Enver Ucbilek, Ali Riza Koksal, Sevil Tokdemir Sisman, Ibrahim Durak, Ilker Sen, Beril Dogu, Erdinc Serin, Ayse Bolat Ucbilek, Makbule Ozge Yildirim, Sukru Mehmet Erturk, Huseyin Alkim, Canan Alkim
    European Journal of Gastroenterology & Hepatology.2022; 34(12): 1261.     CrossRef
Close layer
Namgok Lecture 2020
Diabetes, Obesity and Metabolism
Cellular and Intercellular Homeostasis in Adipose Tissue with Mitochondria-Specific Stress
Min Jeong Choi, Saet-Byel Jung, Joon Young Chang, Minho Shong
Endocrinol Metab. 2021;36(1):1-11.   Published online February 24, 2021
DOI: https://doi.org/10.3803/EnM.2021.956
  • 10,890 View
  • 255 Download
  • 5 Web of Science
  • 5 Crossref
AbstractAbstract PDFPubReader   ePub   
Paracrine interactions are imperative for the maintenance of adipose tissue intercellular homeostasis, and intracellular organelle dysfunction results in local and systemic alterations in metabolic homeostasis. It is currently accepted that mitochondrial proteotoxic stress activates the mitochondrial unfolded protein response (UPRmt) in vitro and in vivo. The induction of mitochondrial chaperones and proteases during the UPRmt is a key cell-autonomous mechanism of mitochondrial quality control. The UPRmt also affects systemic metabolism through the secretion of cell non-autonomous peptides and cytokines (hereafter, metabokines). Mitochondrial function in adipose tissue plays a pivotal role in whole-body metabolism and human diseases. Despite continuing interest in the role of the UPRmt and quality control pathways of mitochondria in energy metabolism, studies on the roles of the UPRmt and metabokines in white adipose tissue are relatively sparse. Here, we describe the role of the UPRmt in adipose tissue, including adipocytes and resident macrophages, and the interactive roles of cell non-autonomous metabokines, particularly growth differentiation factor 15, in local adipose cellular homeostasis and systemic energy metabolism.

Citations

Citations to this article as recorded by  
  • The role and mechanism of UPRmt in adipocytes
    Hao Liu, Jie Chen, Dan-Qi Qiu, Miao-Wei Jiang, Hao-Qi Chen, Li Li, Shu-Qin Chen
    Adipocyte.2026;[Epub]     CrossRef
  • From Microbial Switches to Metabolic Sensors: Rewiring the Gut–Brain Kynurenine Circuit
    Masaru Tanaka, László Vécsei
    Biomedicines.2025; 13(8): 2020.     CrossRef
  • Imeglimin modulates mitochondria biology and facilitates mitokine secretion in 3T3-L1 adipocytes
    Nobuhiko Takahashi, Atsushi P. Kimura, Takayuki Yoshizaki, Kazumasa Ohmura
    Life Sciences.2024; 349: 122735.     CrossRef
  • Mitochondrial stress-induced GFRAL signaling controls diurnal food intake and anxiety-like behavior
    Carla Igual Gil, Bethany M Coull, Wenke Jonas, Rachel N Lippert, Susanne Klaus, Mario Ost
    Life Science Alliance.2022; 5(11): e202201495.     CrossRef
  • Stress-induced FGF21 and GDF15 in obesity and obesity resistance
    Susanne Keipert, Mario Ost
    Trends in Endocrinology & Metabolism.2021; 32(11): 904.     CrossRef
Close layer
Original Article
Clinical Study
Mechanisms of the Impact of Hashimoto Thyroiditis on Papillary Thyroid Carcinoma Progression: Relationship with the Tumor Immune Microenvironment
Oksana Sulaieva, Olena Chernenko, Oleksiy Selesnov, Oleksandr Nechay, Oleksandr Maievskyi, Tetyana Falalyeyeva, Nazarii Kobyliak, Olena Tsyryuk, Yurii Penchuk, Dmytro Shapochka
Endocrinol Metab. 2020;35(2):443-455.   Published online June 24, 2020
DOI: https://doi.org/10.3803/EnM.2020.35.2.443
  • 11,933 View
  • 204 Download
  • 26 Web of Science
  • 27 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
The relationship between Hashimoto thyroiditis (HT) and papillary thyroid carcinoma (PTC) remains uncertain. We assessed the impact of HT on the tumor immune microenvironment (TIME) in PTC.
Methods
Thirty patients with PTC (group 1) and 30 patients with PTC and HT (group 2) were enrolled in this pilot study. The distribution and number of CD8+ lymphocytes, plasma cells (CD138+), regulatory T cells (forkhead box P3 [FOXP3+)], mast cell tryptase (MCT+), and M2 macrophages (CD163+) were evaluated. To test the hypothesis that HT impacts PTC development via signal transducer and activator of transcription 6 (STAT6) activation and M2 macrophage polarization, we investigated STAT6 expression in tumor and stromal cells. We also evaluated vascular endothelial growth factor (VEGF) expression by lymph node metastasis (LNM) status.
Results
TIME showed significant between-group differences. Group 1 patients demonstrated immune desert or immune-excluded immunophenotypes, while an inflamed phenotype with more CD8+ cells (P<0.001) predominated in group 2. Immune-excluded TIME was associated with the highest LNM rate. In PTC, LNM was associated with more numerous CD163+ cells. Moreover, LNM in group 1 was associated with increased numbers of mast cells peritumorally and FOXP3+ cells intratumorally and peritumorally. Group 2 demonstrated higher STAT6 but not higher VEGF expression in tumor cells. High VEGF expression was associated with LNM regardless of HT status.
Conclusion
Concomitant HT impacted PTC signaling via STAT6 and TIME by increasing the number of CD8+ cells. LNM is associated with increases in CD163+ cells and VEGF expression in PTC, whereas HT affected LNM through different mechanisms.

Citations

Citations to this article as recorded by  
  • Papillary Thyroid Carcinoma and Hashimoto’s Thyroiditis: New Insights into the Immunological Link
    Patricia Schott-Ohly, Matthias Schott
    Hormone and Metabolic Research.2026; 58(02): 43.     CrossRef
  • Integrating multi-omics and machine learning to unravel mechanisms of lymph node metastasis in papillary carcinoma with and without thyroiditis
    Shuran Chen, Wencan Yang, Yanyan Liu, Angqing Li
    Frontiers in Immunology.2026;[Epub]     CrossRef
  • Impact of Hashimoto Thyroiditis on Long-Term Outcomes in Differentiated Thyroid Carcinoma
    Jasna Mihailović, Ivana Starčević, Slađana Novković-Ostojić, Tijana Vasiljević, Nataša Prvulović Bunović, Bojana Šćepanović
    Cancers.2026; 18(12): 1938.     CrossRef
  • Immune cells in thyroid adenoma and carcinoma: uncovering a hidden value of assessing tumor-host interplay and its potential application in thyroid cytopathology
    Iryna Omelianenko, Nazarii Kobyliak, Tetyana Falalyeyeva, Oleksii Seleznov, Pavlina Botsun, Lyudmila Ostapchenko, Oleksandr Korotkyi, Liudmyla Domylivska, Olena Tsyryuk, Galyna Mykhalchyshyn, Tetiana Shapochka, Oksana Sulaieva
    Frontiers in Molecular Biosciences.2025;[Epub]     CrossRef
  • Exploring the mechanism of vitamin C on the co-expressed genes of papillary thyroid carcinoma and Epstein-Barr virus based on bioinformatics, network pharmacology and molecular docking analysis
    Dongliang Shi, Liang Chen, Chenhao Li, Meng Yang, Wenhua Yang, Guozhong Cui, Jinzhao Liu, Qianqian Chen
    Discover Oncology.2025;[Epub]     CrossRef
  • Papillary thyroid carcinoma with Hashimoto’s thyroiditis: impact and correlation
    Shengpeng Yao, Hong Zhang
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Mechanisms underlying the promotion of papillary thyroid carcinoma occurrence and progression by Hashimoto’s thyroiditis
    Xiaohui Xue, Deqi Wu, Hangyu Yao, Kainan Wang, Zhengtao Liu, Haijiang Qu
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Research Progress on the Immunological Correlation Between Papillary Thyroid Carcinoma and Hashimoto’s Thyroiditis
    Digui Fang, Limei Zhou, Biao Zheng, Ran Wang
    Journal of Immunology Research.2025;[Epub]     CrossRef
  • Risk Stratification for Thyroid Malignancies in Chronic Lymphocytic Thyroiditis
    Anna Krzentowska, Aleksander Konturek, Filip Gołkowski, Anna Merklinger-Gruchała, Marcin Barczyński
    Cancers.2025; 17(12): 1964.     CrossRef
  • Developments in the study of the role of lactate metabolism in the genesis and progression of thyroid cancer
    Lei Shi, Xuyang Zhong, Jiafeng Liu, Yong Ying, Zibing Liao, Jin Liu, Liwen Zhao, Jianing Zhong, Xiangtai Zeng
    Frontiers in Cell and Developmental Biology.2025;[Epub]     CrossRef
  • Genetic alterations affect immune contexture of non-small cell lung cancer: Ukrainian study
    Denys Kozakov, Nazarii Kobyliak, Sofiia Livshun, Oleksii Seleznov, Olena Koshyk, Alina Matvieieva, Yaroslav Shparyk, Oleksii Kolesnik, Yuliia Moskalenko, Oleksandr Vynnychenko, Roman Moskalenko, Serhii Kropyvko, Anna Khmel, Bogdana Shkarupii, Oksana Sulai
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • The impact of Hashimoto’s thyroiditis on the clinical outcome of papillary thyroid cancer after radioactive iodine therapy: a propensity score matching study
    Jingjia Cao, Yaru Sun, Yang Liu, Yunfei Xu, Xiao Li, Wei Zhang, Ximing Wang
    Endocrine.2024; 87(1): 178.     CrossRef
  • Prognostic role of STAT6 in patients with non-small cell lung cancer
    O. Vynnychenko, Y. Moskalenko, O. Yazykov, I. Tymchenko, O. Seleznov, O. Sulaieva, R. Moskalenko
    Regulatory Mechanisms in Biosystems.2024; 15(4): 868.     CrossRef
  • Clinical significance and diagnostic value of QPCT, SCEL and TNFRSF12A in papillary thyroid cancer
    Tairong Liang, Xiuqian Wu, Lan Wang, Zhengzhong Ni, Ying Fan, Peishan Wu, Hongzhi Wang, Yongdong Niu, Haihua Huang
    Pathology - Research and Practice.2023; 245: 154431.     CrossRef
  • Recommend with caution: A meta-analysis investigating papillary thyroid carcinoma tumor progression under active surveillance
    Peter P. Issa, Ruhul Munshi, Aaron L. Albuck, Mahmoud Omar, Ruba F. Abu Alhuda, Tyler Metz, Mohammad Hussein, Mohamed Shama, Grace S. Lee, Eman Toraih, Emad Kandil
    American Journal of Otolaryngology.2023; 44(6): 103994.     CrossRef
  • Hashimoto's thyroiditis is negatively associated with lymph node metastasis in PTMC
    Hui Huang, Siyuan Xu, Song Ni, Wensheng Liu, Shaoyan Liu
    Journal of Cancer Research and Clinical Oncology.2023; 149(17): 15525.     CrossRef
  • A nomogram based on the risk factors of cervical lymph node metastasis in papillary thyroid carcinoma coexistent with Hashimoto’s thyroiditis
    Huanhuan Miao, Jingwen Zhong, Xuesha Xing, Jiawei Sun, Jiaqi Wu, Chengwei Wu, Yan Yuan, Xianli Zhou, Hongbo Wang
    Clinical Hemorheology and Microcirculation.2023; 85(3): 235.     CrossRef
  • The role of vascular endothelial growth factor in the development of papillary thyroid carcinoma in patients with lymphocytic thyroiditis
    Nese E. GULCELIK, Safak AKIN, Kadriye AYDIN, Cisel AYDIN MERICOZ, Yesim G. GULER TEZEL, Aydan USMAN
    Minerva Endocrinology.2023;[Epub]     CrossRef
  • Identification of Transcriptional Pattern Related to Immune Cell Infiltration With Gene Co-Expression Network in Papillary Thyroid Cancer
    Meiye Li, Jimei Zhang, Zongjing Zhang, Ying Qian, Wei Qu, Zhaoshun Jiang, Baochang Zhao
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • A Potential Nine-lncRNAs Signature Identification and Nomogram Diagnostic Model Establishment for Papillary Thyroid Cancer
    Jin-Ming Yao, Jun-Yu Zhao, Fang-Fang Lv, Xue-Bo Yang, Huan-Jun Wang
    Pathology and Oncology Research.2022;[Epub]     CrossRef
  • Hyperhomocysteinemia in the pathogenesis of cardiovascular and endocrine diseases: translational messages
    Rostyslav KAMINSKY, Andrii YANCHYSHYN, Natalia BELEMETS, Olena KURYK, Inga SAMBORSKA, Iryna DZEVULSKA, Rinaldo PELLICANO
    Minerva Biotechnology and Biomolecular Research.2022;[Epub]     CrossRef
  • Immune Microenvironment of Muscular-Invasive Urothelial Carcinoma: The Link to Tumor Immune Cycle and Prognosis
    Oleksandr Stakhovskyi, Nazarii Kobyliak, Oleg Voylenko, Eduard Stakhovskyi, Roman Ponomarchuk, Oksana Sulaieva
    Cells.2022; 11(11): 1802.     CrossRef
  • Comprehensive analysis of lncRNA-mediated ceRNA regulatory networks and key genes associated with papillary thyroid cancer coexistent with Hashimoto’s thyroiditis
    Yuepeng Zhang, Yueli Tian
    BMC Endocrine Disorders.2022;[Epub]     CrossRef
  • Research Progress in the Correlation between AID, BRAFV600E and Papillary Thyroid Carcinoma
    鑫 焦
    Advances in Clinical Medicine.2022; 12(12): 11503.     CrossRef
  • STAT6: A review of a signaling pathway implicated in various diseases with a special emphasis in its usefulness in pathology
    Georgia Karpathiou, Alexandra Papoudou-Bai, Elise Ferrand, Jean Marc Dumollard, Michel Peoc’h
    Pathology - Research and Practice.2021; 223: 153477.     CrossRef
  • Prevalence of Hashimoto Thyroiditis in Adults With Papillary Thyroid Cancer and Its Association With Cancer Recurrence and Outcomes
    Siyuan Xu, Hui Huang, Jiaxin Qian, Yang Liu, Ying Huang, Xiaolei Wang, Shaoyan Liu, Zhengang Xu, Jie Liu
    JAMA Network Open.2021; 4(7): e2118526.     CrossRef
  • LARINGOPHARINGEAL REFLUX IMPACTS IMMUNE MICROENVIRONMENT OF LARYNGEAL CARCINOMA
    D.I. Zabolotnyi, V.V. Kizim, D.D. Zabolotna, Y.V. Kizim, O.N. Sulaieva
    Fiziolohichnyĭ zhurnal.2020; 66(4): 12.     CrossRef
Close layer
Review Article
The Role of Macrophage Lipophagy in Reverse Cholesterol Transport
Se-Jin Jeong, Mi-Ni Lee, Goo Taeg Oh
Endocrinol Metab. 2017;32(1):41-46.   Published online March 20, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.1.41
  • 11,926 View
  • 113 Download
  • 48 Web of Science
  • 51 Crossref
AbstractAbstract PDFPubReader   

Macrophage cholesterol efflux is a central step in reverse cholesterol transport, which helps to maintain cholesterol homeostasis and to reduce atherosclerosis. Lipophagy has recently been identified as a new step in cholesterol ester hydrolysis that regulates cholesterol efflux, since it mobilizes cholesterol from lipid droplets of macrophages via autophagy and lysosomes. In this review, we briefly discuss recent advances regarding the mechanisms of the cholesterol efflux pathway in macrophage foam cells, and present lipophagy as a therapeutic target in the treatment of atherosclerosis.

Citations

Citations to this article as recorded by  
  • Lipid droplets beyond storage: Cellular metabolic modulator in the diabetic heart (Review)
    Yongchun Liang, Xinbiao Fan, Xiaofei Geng, Yunfeng Jia, Wenyu Shang, Xitong Sun, Jun Ge, Guijun Ye, Boyu Zhu, Zheng Zhang, Yuxin Kang, Xiaoyu Shan, Junping Zhang
    International Journal of Molecular Medicine.2026; 57(4): 1.     CrossRef
  • Expression of IMD-CBM peptide induces the autophagic degradation of CAV1 (caveolin 1) to inhibit LDL transcytosis and retard diabetic atherosclerosis
    Li Wang, Xiong Jia, Xiangli Bai, Ying Zhao, Wenzhuo Cheng, Meng Shu, Yan Shu, Liyin Zhang, Ruonan Wang, Si Jin
    Autophagy.2026; 22(6): 1273.     CrossRef
  • The role of selective autophagy in cardiovascular diseases: mechanisms and therapeutic potential
    Ting Zeng, Zhongjian Zhang, Chunliu Qian, Xiaoyu Li, Shuang Li
    The Journal of Cardiovascular Aging.2026;[Epub]     CrossRef
  • Hexosamine Biosynthetic Pathway and Fatty Acid β-Oxidative Imbalance: A Key Mechanism by Which Abnormal Macrophage Lipophagy Promotes Atherosclerosis in Diabetes
    Jin-ping Liu, Yu-hui Liu, Hao Luo, Yi-fei Wu, Shuai-yi Yu, Ya Wu, Yong Liu
    Cardiovascular Drugs and Therapy.2026;[Epub]     CrossRef
  • Phospholipid Transfer Protein (PLTP) in Cholesterol Handling: Implications for Mitochondrial Lipid Homeostasis in Human iPSC-Derived Cardiomyocytes
    Dhienda C. Shahannaz, Tadahisa Sugiura
    International Journal of Molecular Sciences.2026; 27(8): 3617.     CrossRef
  • Dual modulation of lipophagy: From molecular mechanisms to therapeutic interventions in cardiovascular health and disease
    Yunxia Wu, Weili Li, Heng Liu, Fei Ge, Guanjing Ling, Yawen Zhang, Yuqin Zhang, Yilin Li, Yan Wei, Shujuan Guo, Wei Wang, Yong Wang
    Pharmacological Research.2026; 228: 108204.     CrossRef
  • Fatty acid metabolism and lipid channeling in macrophages: mechanisms of inflammation, resolution, and lipotoxicity
    Temitayo T. Bamgbose, Oluwakemi O. Igiehon, Javier Nion-Fieira, Cora R. Palmer, Andrii Andriichuk, Matthew D. Woolard
    Frontiers in Immunology.2026;[Epub]     CrossRef
  • From lipid overload to autophagy collapse: how lipid dysregulation drives chronic inflammation and metabolic disease
    Mykyta Fomin, Konstantin Zapf, Elisabeth Schieffer, Johannes Freitag, Gert Bange, Bernhard Schieffer
    Inflammation Research.2026;[Epub]     CrossRef
  • Protective Effect of Natural Phenolic Acids, Rosmarinic Acid and Salvianolic Acid, Against Diabetic Atherosclerosis
    Yaeram Won, Hye Jung Kim
    International Journal of Molecular Sciences.2026; 27(15): 6625.     CrossRef
  • Sex-specific transcriptional regulation in lung macrophages during sub-acute Mycobacterium tuberculosis infection
    Dhanya Dhanyalayam, Hariprasad Thangavel, Kezia Lizardo, Jigar V. Desai, Jyothi F. Nagajyothi, Prabagaran Narayanasamy
    Microbiology Spectrum.2025;[Epub]     CrossRef
  • Tianxiangdan suppresses foam cell formation by enhancing lipophagy and reduces the progression of atherosclerosis
    Ya-jie Zhang, Huan He, Guligena Sawuer, Xue-kuan Ma, Zulihumaer Ainiwaer, Dan-dan Wu, Xia-xia Zhang, Dong-qing An
    In Vitro Cellular & Developmental Biology - Animal.2025; 61(3): 298.     CrossRef
  • Cellular stress and macrophage activation
    Jing Yu, Bin-Zhi Qian
    Seminars in Immunology.2025; 78: 101953.     CrossRef
  • The converging roles of microRNAs and lipid metabolism in atherosclerotic cardiovascular disease and cancer
    Sandra Vladimirov, Marija Tomasevic, Nemanja Popov, Jelena Munjas, David de Gonzalo-Calvo, Miron Sopic
    Seminars in Cancer Biology.2025; 114: 41.     CrossRef
  • ApoA1-driven cholesterol efflux and macrophage polarization orchestrate T-cell differentiation towards controlling Leishmania donovani pathogenesis
    Vikash Kumar, Dayakar Alti, Shobha Kumari, Ravi Ranjan, Divya Prasad, Veer Singh, Abhik Sen, Pradeep Das, Krishna Pandey, Ashish Kumar
    Scientific Reports.2025;[Epub]     CrossRef
  • The mitochondrial translocator protein (TSPO, 18 kDa): A key multifunctional molecule in liver diseases
    Yuchang Li, Liting Chen, Vassilios Papadopoulos
    Biochimie.2024; 224: 91.     CrossRef
  • Bile salt signaling and bile salt-based therapies in cardiometabolic disease
    Claire C.J. Groenen, Thuc-Anh Nguyen, Coen C. Paulusma, Stan F.J. van de Graaf
    Clinical Science.2024; 138(1): 1.     CrossRef
  • Insights into the role of FGF21 in coronary heart disease
    Qin-Yao Zhang, Hui-Xin Liu
    International Journal of Biological Macromolecules.2024; 282: 136911.     CrossRef
  • Mechanistic insights into the regression of atherosclerotic plaques
    Jianshu Song, Ce Cao, Ziyan Wang, Haoran Li, Lili Yang, Jing Kang, Hongxu Meng, Lei Li, Jianxun Liu
    Frontiers in Physiology.2024;[Epub]     CrossRef
  • Huazhuotongmai decoction exerts anti-atherosclerotic effects by modulating the expression of ABCA1/SR-B1/PPAR-γ in vivo and in vitro
    Ya-ru Yan, Zi-jun Jia, Ya Wang, Feng-qin Xu, Qing-bing Zhou
    Phytomedicine Plus.2023; 3(2): 100436.     CrossRef
  • The SGLT2 Inhibitor Canagliflozin Reduces Atherosclerosis by Enhancing Macrophage Autophagy
    Hongping Chen, Da Teng, Bowen Xu, Chunxiao Wang, Hua Wang, Wenjuan Jia, Lei Gong, Haibin Dong, Lin Zhong, Jun Yang
    Journal of Cardiovascular Translational Research.2023; 16(5): 999.     CrossRef
  • FURIN suppresses the progression of atherosclerosis by promoting macrophage autophagy
    Hongping Chen, Lihui Zhang, Shaohua Mi, Hua Wang, Chunxiao Wang, Wenjuan Jia, Lei Gong, Haibin Dong, Bowen Xu, Yanyan Jing, Peipei Ge, Zhigang Pei, Lin Zhong, Jun Yang
    The FASEB Journal.2023;[Epub]     CrossRef
  • Unbalanced Redox With Autophagy in Cardiovascular Disease
    Se-Jin Jeong, Goo Taeg Oh
    Journal of Lipid and Atherosclerosis.2023; 12(2): 132.     CrossRef
  • Edible Bird’s Nest Effectively Attenuates Atherosclerosis through Modulation of Cholesterol Metabolism via Activation of PPARγ/LXRα Signaling Pathway In Vivo
    Nurul Nadiah Mohamad Nasir, Ramlah Mohamad Ibrahim, Rozi Mahmud, Nor Asma Ab Razak, Norsharina Ismail, Kim Wei Chan, Md Zuki Abu Bakar, Akhilesh K. Verma
    Journal of Food Biochemistry.2023; 2023: 1.     CrossRef
  • The Differential Metabolomes in Cumulus and Mural Granulosa Cells from Human Preovulatory Follicles
    Er-Meng Gao, Bongkoch Turathum, Ling Wang, Di Zhang, Yu-Bing Liu, Rong-Xin Tang, Ri-Cheng Chian
    Reproductive Sciences.2022; 29(4): 1343.     CrossRef
  • PHLPP1 promotes neutral lipid accumulation through AMPK/ChREBP-dependent lipid uptake and fatty acid synthesis pathways
    Keerthana Balamurugan, Raghavender Medishetti, Jyothi Kotha, Parameshwar Behera, Kanika Chandra, Vijay Aditya Mavuduru, Manjunath B. Joshi, Ramesh Samineni, Madhumohan R. Katika, Writoban Basu Ball, Manjunatha Thondamal, Anil Challa, Kiranam Chatti, Kisho
    iScience.2022; 25(2): 103766.     CrossRef
  • Hydrochloride Berberine ameliorates alcohol-induced liver injury by regulating inflammation and lipid metabolism
    Xiumei Ke, Ruoyu Zhang, Pan Li, Ling Zuo, Meng Wang, Junxuan Yang, Jianwei Wang
    Biochemical and Biophysical Research Communications.2022; 610: 49.     CrossRef
  • Metabolic Regulation of Macrophage Activation
    Ourania Kolliniati, Eleftheria Ieronymaki, Eleni Vergadi, Christos Tsatsanis
    Journal of Innate Immunity.2022; 14(1): 51.     CrossRef
  • Emerging Roles of Lipophagy in Cancer Metastasis
    Haimeng Yin, Ying Shan, Tian Xia, Yan Ji, Ling Yuan, Yiwen You, Bo You
    Cancers.2022; 14(18): 4526.     CrossRef
  • Genetic Factors for Coronary Heart Disease and Their Mechanisms: A Meta-Analysis and Comprehensive Review of Common Variants from Genome-Wide Association Studies
    Khairul Anwar Zarkasi, Noraidatulakma Abdullah, Nor Azian Abdul Murad, Norfazilah Ahmad, Rahman Jamal
    Diagnostics.2022; 12(10): 2561.     CrossRef
  • Caveolin-1 in autophagy: A potential therapeutic target in atherosclerosis
    Kai Hou, Shuai Li, Meng Zhang, Xuping Qin
    Clinica Chimica Acta.2021; 513: 25.     CrossRef
  • Contradictory regulation of macrophages on atherosclerosis based on polarization, death and autophagy
    Jing Zhang, Chuan-Rui Ma, Yun-Qing Hua, Lan Li, Jing-Yu Ni, Yu-Ting Huang, Sophia Esi Duncan, Sheng Li, Shan Gao, Guan-Wei Fan
    Life Sciences.2021; 276: 118957.     CrossRef
  • A meta-analysis of HDL cholesterol efflux capacity and concentration in patients with rheumatoid arthritis
    Binbin Xie, Jiang He, Yong Liu, Ting Liu, Chaoqun Liu
    Lipids in Health and Disease.2021;[Epub]     CrossRef
  • Rosmarinic Acid Increases Macrophage Cholesterol Efflux through Regulation of ABCA1 and ABCG1 in Different Mechanisms
    Jean-Baptiste Nyandwi, Young Shin Ko, Hana Jin, Seung Pil Yun, Sang Won Park, Hye Jung Kim
    International Journal of Molecular Sciences.2021; 22(16): 8791.     CrossRef
  • FGF21 induces autophagy‐mediated cholesterol efflux to inhibit atherogenesis via RACK1 up‐regulation
    Lin Xiaolong, Guo Dongmin, Mihua Liu, Wang Zuo, Hu Huijun, Tan Qiufen, Hu XueMei, Lin Wensheng, Pan Yuping, Lin Jun, Zeng Zhaolin
    Journal of Cellular and Molecular Medicine.2020; 24(9): 4992.     CrossRef
  • Lipophagy in atherosclerosis
    Qing Liu, Yuan-Mei Wang, Hong-Feng Gu
    Clinica Chimica Acta.2020; 511: 208.     CrossRef
  • Lysosomotropic Features and Autophagy Modulators among Medical Drugs: Evaluation of Their Role in Pathologies
    Tatiana A. Korolenko, Thomas P. Johnston, Vaclav Vetvicka
    Molecules.2020; 25(21): 5052.     CrossRef
  • LncRNA MALAT1 Enhances ox-LDL-Induced Autophagy through the SIRT1/MAPK/NF-κB Pathway in Macrophages
    Jiaqi Yang, Xuze Lin , Liangshan Wang, Tienan Sun, Qi Zhao, Qian Ma, Yujie Zhou
    Current Vascular Pharmacology.2020; 18(6): 652.     CrossRef
  • Autophagy in chronic stress induced atherosclerosis
    Na Li, Ru-Xin Zhang, Xue-Jiao Xie, Hong-Feng Gu
    Clinica Chimica Acta.2020; 503: 70.     CrossRef
  • CTRP13 inhibits atherosclerosis via autophagy‐lysosome‐dependent degradation of CD36
    Cheng Wang, Wenjing Xu, Minglu Liang, Dan Huang, Kai Huang
    The FASEB Journal.2019; 33(2): 2290.     CrossRef
  • Subclinical atherosclerosis and its progression are modulated by PLIN2 through a feed‐forward loop between LXR and autophagy
    P. Saliba‐Gustafsson, M. Pedrelli, K. Gertow, O. Werngren, V. Janas, S. Pourteymour, D. Baldassarre, E. Tremoli, F. Veglia, R. Rauramaa, A.J. Smit, P. Giral, S. Kurl, M. Pirro, U. de Faire, S.E. Humphries, A. Hamsten, I. Gonçalves, M. Orho‐Melander, A. Fr
    Journal of Internal Medicine.2019; 286(6): 660.     CrossRef
  • PCSK9: A new participant in lipophagy in regulating atherosclerosis?
    Jun Xiao, Yi-Min Deng, Xiang-Rui Liu, Jian-Ping Cao, Min Zhou, Ya-Ling Tang, Wen-Hao Xiong, Zhi-Sheng Jiang, Zhi-Han Tang, Lu-Shan Liu
    Clinica Chimica Acta.2019; 495: 358.     CrossRef
  • Autophagy-Mediated Cholesterol Trafficking Controls Steroid Production
    Michael J. Texada, Alina Malita, Christian F. Christensen, Kathrine B. Dall, Nils J. Faergeman, Stanislav Nagy, Kenneth A. Halberg, Kim Rewitz
    Developmental Cell.2019; 48(5): 659.     CrossRef
  • Lipophagy in nonliver tissues and some related diseases: Pathogenic and therapeutic implications
    Kebing Zhou, Pingbo Yao, Jun He, Hong Zhao
    Journal of Cellular Physiology.2019; 234(6): 7938.     CrossRef
  • Autophagy differentially regulates macrophage lipid handling depending on the lipid substrate (oleic acid vs. acetylated-LDL) and inflammatory activation state
    Sapir Hadadi-Bechor, Yulia Haim, Tal Pecht, Roni Gat, Tanya Tarnovscki, Martin Gericke, Assaf Rudich
    Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.2019; 1864(12): 158527.     CrossRef
  • Autophagy and Age-Related Eye Diseases
    Xue Yang, Xinan Pan, Xiaorui Zhao, Jin Luo, Mingpu Xu, Daoming Bai, Yan Hu, Xu Liu, Qiongfang Yu, Dian Gao
    BioMed Research International.2019; 2019: 1.     CrossRef
  • Foam cell formation and cholesterol trafficking and metabolism disturbances in atherosclerosis
    Alexandrina Volobueva, Dongwei Zhang, Andrey V. Grechko, Alexander N. Orekhov
    Cor et Vasa.2019; 61(1): 48.     CrossRef
  • Oxidative Stress, Lipid Peroxidation, and Loss of Hyaluronic Acid in the Human Vitreous Affected by Synchysis Scintillans
    Loredana Bergandi, Oleksii A Skorokhod, Rosalba La Grotta, Evelin Schwarzer, Raffaele Nuzzi
    Journal of Ophthalmology.2019; 2019: 1.     CrossRef
  • Programmed cell death protein 4 deficiency suppresses foam cell formation by activating autophagy in advanced glycation end‐product low‐density lipoprotein–induced macrophages
    Shan Li, Guangdong Gao, Fuyun Wu, Dan Liu, Hongyan Zhao, Jing Ke, Ying Liu, Fei Li, Jian Li, Zongyun Chen, Zhiming Tang, Lei Bai, Jinxuan Zhang, Wei Zheng, Xin Chen
    Journal of Cellular Biochemistry.2019; 120(5): 7689.     CrossRef
  • Mindin deficiency in macrophages protects against foam cell formation and atherosclerosis by targeting LXR-β
    Cheng Zhang, Juan-Juan Qin, Fu-Han Gong, Jing-Jing Tong, Wen-Lin Cheng, Haiping Wang, Yan Zhang, Xueyong Zhu, Zhi-Gang She, Hao Xia, Li-Hua Zhu
    Clinical Science.2018; 132(11): 1199.     CrossRef
  • LJ-1888, a selective antagonist for the A3 adenosine receptor, ameliorates the development of atherosclerosis and hypercholesterolemia in apolipoprotein E knock-out mice
    Jong-Gil Park, Se-Jin Jeong, Jinha Yu, Gyudong Kim, Lak Shin Jeong, Goo Taeg Oh
    BMB Reports.2018; 51(10): 520.     CrossRef
  • Intracellular and Plasma Membrane Events in Cholesterol Transport and Homeostasis
    Dmitry Y. Litvinov, Eugeny V. Savushkin, Alexander D. Dergunov
    Journal of Lipids.2018; 2018: 1.     CrossRef
Close layer
Original Articles
Endocrine Research
Macrophage Densities Correlated with CXC Chemokine Receptor 4 Expression and Related with Poor Survival in Anaplastic Thyroid Cancer
Dae In Kim, Eunyoung Kim, Young A Kim, Sun Wook Cho, Jung Ah Lim, Young Joo Park
Endocrinol Metab. 2016;31(3):469-475.   Published online August 2, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.3.469
  • 8,897 View
  • 58 Download
  • 29 Web of Science
  • 24 Crossref
AbstractAbstract PDFPubReader   
Background

Tumor associated macrophages (TAMs) and CXC chemokine receptor 4 (CXCR4) have emerged as potential biomarkers in various human cancers. The aims of this study were to investigate the clinical characteristics of anaplastic thyroid cancer (ATC) patients according to the TAM numbers in the tumor tissue, and to evaluate the associations between CXCR4 expressions and macrophage densities in ATC tumor microenvironment.

Methods

Total 14 ATC samples from thyroid tissue microarray were used. Immunohistochemical staining was performed using anti-CD163 and anti-CXCR4 antibodies. According to the immunoreactivity of CD163, all subjects were divided into two groups: low-CD163 (n=8) and high-CD163 (n=6) groups.

Results

The mean diagnostic age was 65±7 years and the median tumor size was 4.3 cm, ranging 2.5 to 15 cm. Clinicopathological characteristics were not significantly different between low-CD163 and high-CD163 groups, while age of diagnosis was younger in high-CD163 group than that of low-CD163 group with marginal significance (56.9±5.5 years vs. 67.5±6.8 years, P=0.09). However, overall survival was significantly reduced in high-CD163 group (5.5 months [range, 1 to 10]) compared with low-CD163 groups (8.8 months [range, 6 to 121); log-rank test, P=0.0443). Moreover, high-CD163 group showed strong CXCR4 expressions in both cancer and stromal compartments, while low-CD163 group showed relatively weak, stromal-dominant CXCR4 expressions. Additionally, CD163 and CXCR4 expressions showed a strong positive correlation (γ2=0.432, P=0.013).

Conclusion

Increased number of TAMs showed poor overall survival in ATC, suggesting TAMs are potentially a prognostic biomarker for ATC. CXCR4 expression was significantly correlated with CD163-positive TAM densities, which suggest the possible role of CXCR4 in TAM recruitments.

Citations

Citations to this article as recorded by  
  • Cancer Stemness and Dedifferentiation in Anaplastic Thyroid Carcinoma: Insights into a Multigenic, Microenvironmental Network and the Role of CD44
    Benny Mosoane, Brandon S. Jackson, Michelle McCabe, Tebogo Marutha, Zodwa Dlamini
    Biomedicines.2026; 14(2): 453.     CrossRef
  • HN1/CEBPB/CCL2 signaling shapes VSIG4+ tumor-associated macrophages in anaplastic thyroid carcinoma
    Ziwen Fang, Ying Li, Xiaoping Hu, Jinming Chen, Zixue Xuan, Shanshan Wang, Rui Zhao, Ruidan Zhang, Yixuan Wang, Ping Huang, Jiafeng Wang, Zongfu Pan
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2026; 1872(7): 168303.     CrossRef
  • Routine Blood Tests as Predictive Tools for Differentiating Follicular Thyroid Carcinoma From Follicular Adenoma
    Jiaxi Wang, Jingwei Wang, Hanqing Liu, Chuang Chen
    International Journal of General Medicine.2025; Volume 18: 733.     CrossRef
  • Anaplastic thyroid cancer: Genetic roles, targeted therapy, and immunotherapy
    Zhao Zou, Linhong Zhong
    Genes & Diseases.2025; 12(4): 101403.     CrossRef
  • Turning tumor microenvironmental foes to friends: A new opportunity for thyroid cancer therapy and redifferentiation
    Liya Zhu, Xiuli Jing, Byeong-Cheol Ahn
    Oral Oncology.2025; 168: 107513.     CrossRef
  • Expression of Sodium Iodide Symporter in Breast Cancer Tissue after Thyroid Cancer
    Ye An Kim, Hye Sook Min, Hwa Young Ahn, Young A Kim, Young Joo Park
    International Journal of Thyroidology.2025; 18(2): 157.     CrossRef
  • Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy
    Naimah Turner, Sarah Hamidi, Rim Ouni, Rene Rico, Ying C. Henderson, Maria Puche, Sayan Alekseev, Jocelynn G. Colunga-Minutti, Mark E. Zafereo, Stephen Y. Lai, Sang T. Kim, Maria E. Cabanillas, Roza Nurieva
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Immune microenvironment in papillary thyroid carcinoma: roles of immune cells and checkpoints in disease progression and therapeutic implications
    Xun Zheng, Ruonan Sun, Tao Wei
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • IL2RA+VSIG4+ tumor-associated macrophage is a key subpopulation of the immunosuppressive microenvironment in anaplastic thyroid cancer
    Zongfu Pan, Lisha Bao, Xixuan Lu, Xiaoping Hu, Lu Li, Jinming Chen, Tiefeng Jin, Yiwen Zhang, Zhuo Tan, Ping Huang, Minghua Ge
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2023; 1869(1): 166591.     CrossRef
  • Crosstalk between Thyroid Carcinoma and Tumor-Correlated Immune Cells in the Tumor Microenvironment
    Mingyuan Song, Qi Liu, Wei Sun, Hao Zhang
    Cancers.2023; 15(10): 2863.     CrossRef
  • Modeling the tumor microenvironment of anaplastic thyroid cancer: an orthotopic tumor model in C57BL/6 mice
    Zhen Xu, Hyo Shik Shin, Yoo Hyung Kim, Seong Yun Ha, Jae-Kyung Won, Su-jin Kim, Young Joo Park, Sareh Parangi, Sun Wook Cho, Kyu Eun Lee
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Tumor-associated macrophages as a potential therapeutic target in thyroid cancers
    Liya Zhu, Xiu Juan Li, Prakash Gangadaran, Xiuli Jing, Byeong-Cheol Ahn
    Cancer Immunology, Immunotherapy.2023; 72(12): 3895.     CrossRef
  • Functional Phenotypes of Peritoneal Macrophages Upon AMD3100 Treatment During Colitis-Associated Tumorigenesis
    Shuai Wu, Weiwei Luo, Xing Wu, Zhaohua Shen, Xiaoyan Wang
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Integrated analysis of novel macrophage related signature in anaplastic thyroid cancer
    Yi Luo, Yi-Chen Yang, Ben Ma, Wei-Bo Xu, Tian Liao, Yu Wang
    Endocrine.2022; 78(3): 517.     CrossRef
  • Secreted Factors by Anaplastic Thyroid Cancer Cells Induce Tumor-Promoting M2-like Macrophage Polarization through a TIM3-Dependent Mechanism
    Cinthia Carolina Stempin, Romina Celeste Geysels, Sunmi Park, Luz Maria Palacios, Ximena Volpini, Claudia Cristina Motran, Eva Virginia Acosta Rodríguez, Juan Pablo Nicola, Sheue-yann Cheng, Claudia Gabriela Pellizas, Laura Fozzatti
    Cancers.2021; 13(19): 4821.     CrossRef
  • Immunotherapy for anaplastic thyroid carcinoma: the present and future
    Xixuan LU, Lisha BAO, Zongfu PAN, Minghua GE
    Journal of Zhejiang University (Medical Sciences).2021; 50(6): 675.     CrossRef
  • CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy
    Ashraf Mousavi
    Immunology Letters.2020; 217: 91.     CrossRef
  • Nobiletin Alone or in Combination with Cisplatin Decreases the Viability of Anaplastic Thyroid Cancer Cell Lines
    Diana P. Sousa, Marta Pojo, Ana T. Pinto, Valeriano Leite, Ana Teresa Serra, Branca M. Cavaco
    Nutrition and Cancer.2020; 72(2): 352.     CrossRef
  • The Thyroid Tumor Microenvironment: Potential Targets for Therapeutic Intervention and Prognostication
    Laura MacDonald, Jonathan Jenkins, Grace Purvis, Joshua Lee, Aime T. Franco
    Hormones and Cancer.2020; 11(5-6): 205.     CrossRef
  • Mouse Models as a Tool for Understanding Progression in BrafV600E-Driven Thyroid Cancers
    Iñigo Landa, Jeffrey A. Knauf
    Endocrinology and Metabolism.2019; 34(1): 11.     CrossRef
  • Low Lymphocyte-to-Monocyte Ratios Are Associated with Poor Overall Survival in Anaplastic Thyroid Carcinoma Patients
    Jonghwa Ahn, Eyun Song, Hye-Seon Oh, Dong Eun Song, Won Gu Kim, Tae Yong Kim, Won Bae Kim, Young Kee Shong, Min Ji Jeon
    Thyroid®.2019; 29(6): 824.     CrossRef
  • Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy
    Christian M. Schürch, Matthias A. Roelli, Stefan Forster, Marie-Hélène Wasmer, Frido Brühl, Renaud S. Maire, Sergio Di Pancrazio, Marc-David Ruepp, Roland Giger, Aurel Perren, Anja M. Schmitt, Philippe Krebs, Roch-Philippe Charles, Matthias S. Dettmer
    Thyroid®.2019; 29(7): 979.     CrossRef
  • Recent advances and emerging therapies in anaplastic thyroid carcinoma
    Maria E. Cabanillas, Mark Zafereo, Michelle D. Williams, Renata Ferrarotto, Ramona Dadu, Neil Gross, G. Brandon Gunn, Heath Skinner, Gilbert Cote, Horiana B. Grosu, Priyanka Iyer, Naifa L. Busaidy
    F1000Research.2018; 7: 87.     CrossRef
  • Pathological processes and therapeutic advances in radioiodide refractory thyroid cancer
    Marika H Tesselaar, Johannes W Smit, James Nagarajah, Romana T Netea-Maier, Theo S Plantinga
    Journal of Molecular Endocrinology.2017; 59(4): R141.     CrossRef
Close layer
Thyroid
The Expression of Tumor-Associated Macrophages in Papillary Thyroid Carcinoma
Seunghwan Kim, Sun Wook Cho, Hye Sook Min, Kang Min Kim, Gye Jeong Yeom, Eun Young Kim, Kyu Eun Lee, Yeo Gyu Yun, Do Joon Park, Young Joo Park
Endocrinol Metab. 2013;28(3):192-198.   Published online September 13, 2013
DOI: https://doi.org/10.3803/EnM.2013.28.3.192
  • 10,129 View
  • 54 Download
  • 49 Crossref
AbstractAbstract PDFPubReader   
Background

Tumor-associated macrophages (TAMs) play a tumorigenic role related to advanced staging and poor prognosis in many human cancers including thyroid cancers. Yet, a functional role of TAMs in papillary thyroid carcinoma (PTC) has not been established. The aim of this study was to investigate TAM expression in human PTC with lymph node (LN) metastasis.

Methods

Thirty-six patients who underwent surgery after being diagnosed with PTC with LN metastasis were included. Primary tumor tissues were immunohistochemically stained with an anti-CD68 antibody and clinical characteristics according to TAM density were evaluated.

Results

The TAM densities (CD68+ cells) varied from 5% to 70%, in all tumor areas, while few cells were stained in adjacent normal tissues. TAMs were identified as CD68+ cells with thin, elongated cytoplasmic extensions that formed a canopy structure over tumor cells. Comparing clinicopathologic characteristics between tumors with low (<25%) and high (25% to 70%) TAM densities, primary tumors were larger in the high density group than in the low density group (2.0±0.1 vs. 1.5±0.1; P=0.009).

Conclusion

TAMs were identified in primary PTC tumors with LN metastasis and higher TAM densities were related to larger tumor sizes, suggesting a tumorigenic role of TAMs in human PTCs.

Citations

Citations to this article as recorded by  
  • Single-cell sequencing reveals the tumor immune microenvironment in thyroid cancer: a narrow review
    Kangcong Liang, Ziyu Wang, Zhiqiang Zhang, Gengluan Liu, Xidi Wang, Heng Cao, Ming Zhong, Liping Ye, Xin Zhong, Jingyu Xun, Kefeng Lei, Ningning Li
    Frontiers in Immunology.2026;[Epub]     CrossRef
  • TIM3 as a therapeutic target in anaplastic thyroid cancer: upregulation in M2‐like macrophages induced by tumor microenvironment‐derived TGFβ1
    Agustina Jaroszewski, Yeon‐Sook Choi, Florencia Hellriegel, Wei Zhang, Fernando Carrizo, Dong Eun Song, María Victoria Laborie, Marcelo Ruggieri, Emiliano Peretti, María Victoria Banus, Cinthia Carolina Stempin, Juan Pablo Nicola, Eva Virginia Acosta Rodr
    The Journal of Pathology.2026;[Epub]     CrossRef
  • Exploring the role of immunotherapy in the management of follicular cell-derived thyroid cancer
    Paige Benson, Omar Abdel-Rahman
    Immunotherapy.2025; 17(1): 47.     CrossRef
  • Macrophage abundance in oncocytic thyroid cancer is associated with PD-L1 expression
    Julio C Ricarte-Filho, Caitlin O Caperton, Amber Isaza, Nicole A Massoll, Aime T Franco
    Endocrine Oncology.2025;[Epub]     CrossRef
  • Single-cell RNA-seq reveals MIF−(CD74 + CXCR4) dependent inhibition of macrophages in metastatic papillary thyroid carcinoma
    Wei Chen, Xinnian Yu, Huixin Li, Shenglong Yuan, Yuqi Fu, Huanhuan Hu, Fangzhou Liu, Yuan Zhang, Shanliang Zhong
    Oral Oncology.2024; 148: 106654.     CrossRef
  • Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy
    Naimah Turner, Sarah Hamidi, Rim Ouni, Rene Rico, Ying C. Henderson, Maria Puche, Sayan Alekseev, Jocelynn G. Colunga-Minutti, Mark E. Zafereo, Stephen Y. Lai, Sang T. Kim, Maria E. Cabanillas, Roza Nurieva
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Thyroid Gland Diffuse Lipomatosis: A Case Study and Comprehensive Literature Review
    Angeliki Emmanouilidou, Michail Karanikas, Kalliopi Pazaitou-Panayiotou, Nickos Michalopoulos
    Journal of Clinical Medicine.2024; 13(21): 6376.     CrossRef
  • H2AFX might be a prognostic biomarker for hepatocellular carcinoma
    Hailiang Hu, Tao Zhong, Suwei Jiang
    Cancer Reports.2023;[Epub]     CrossRef
  • The Tumor Microenvironment and the Estrogen Loop in Thyroid Cancer
    Nerina Denaro, Rebecca Romanò, Salvatore Alfieri, Alessia Dolci, Lisa Licitra, Imperia Nuzzolese, Michele Ghidini, Claudia Bareggi, Valentina Bertaglia, Cinzia Solinas, Ornella Garrone
    Cancers.2023; 15(9): 2458.     CrossRef
  • New Insights into Immune Cells and Immunotherapy for Thyroid Cancer
    Yujia Tao, Peng Li, Chao Feng, Yuan Cao
    Immunological Investigations.2023; 52(8): 1039.     CrossRef
  • Roles and new Insights of Macrophages in the Tumor Microenvironment of Thyroid Cancer
    Qi Liu, Wei Sun, Hao Zhang
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • Construction of a Tumor Immune Microenvironment-Related Prognostic Model in BRAF-Mutated Papillary Thyroid Cancer
    Yuxiao Xia, Xue Jiang, Yuan Huang, Qian Liu, Yin Huang, Bo Zhang, Zhanjun Mei, Dongkun Xu, Yuhong Shi, Wenling Tu
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Identification and Validation of Prognostic Related Hallmark ATP-Binding Cassette Transporters Associated With Immune Cell Infiltration Patterns in Thyroid Carcinoma
    Lidong Wang, Xiaodan Sun, Jingni He, Zhen Liu
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Unraveling the Effects of Carotenoids Accumulation in Human Papillary Thyroid Carcinoma
    Alessandra di Masi, Rosario Luigi Sessa, Ylenia Cerrato, Gianni Pastore, Barbara Guantario, Roberto Ambra, Michael Di Gioacchino, Armida Sodo, Martina Verri, Pierfilippo Crucitti, Filippo Longo, Anda Mihaela Naciu, Andrea Palermo, Chiara Taffon, Filippo A
    Antioxidants.2022; 11(8): 1463.     CrossRef
  • What is the status of immunotherapy in thyroid neoplasms?
    Alejandro Garcia-Alvarez, Jorge Hernando, Ana Carmona-Alonso, Jaume Capdevila
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Matrix Metalloproteinase 9 Expression by Immunohistochemistry in Intratumor Macrophages as Tumor-Associated Macrophage Marker of Papillary Thyroid Carcinoma
    Ni Wayan Armerinayanti, Samuel Widodo, Desak Putu Oki Lestari
    Biomedical and Pharmacology Journal.2022; 15(3): 1671.     CrossRef
  • Cell Component and Function of Tumor Microenvironment in Thyroid Cancer
    Eunah Shin, Ja Seung Koo
    International Journal of Molecular Sciences.2022; 23(20): 12578.     CrossRef
  • Potential diagnostic of lymph node metastasis and prognostic values of TM4SFs in papillary thyroid carcinoma patients
    Kun Wang, Haomin Li, Junyu Zhao, Jinming Yao, Yiran Lu, Jianjun Dong, Jie Bai, Lin Liao
    Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
  • Thyroid Cancer Stem-Like Cells: From Microenvironmental Niches to Therapeutic Strategies
    Elisa Stellaria Grassi, Viola Ghiandai, Luca Persani
    Journal of Clinical Medicine.2021; 10(7): 1455.     CrossRef
  • Immune Landscape of Thyroid Cancers: New Insights
    Elisa Menicali, Martina Guzzetti, Silvia Morelli, Sonia Moretti, Efisio Puxeddu
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • FOXE1-Dependent Regulation of Macrophage Chemotaxis by Thyroid Cells In Vitro and In Vivo
    Sara Credendino, Marta De Menna, Irene Cantone, Carmen Moccia, Matteo Esposito, Luigi Di Guida, Mario De Felice, Gabriella De Vita
    International Journal of Molecular Sciences.2021; 22(14): 7666.     CrossRef
  • Senescent Thyrocytes, Similarly to Thyroid Tumor Cells, Elicit M2-like Macrophage Polarization In Vivo
    Mara Mazzoni, Giuseppe Mauro, Lucia Minoli, Loredana Cleris, Maria Chiara Anania, Tiziana Di Marco, Emanuela Minna, Sonia Pagliardini, Maria Grazia Rizzetti, Giacomo Manenti, Maria Grazia Borrello, Eugenio Scanziani, Angela Greco
    Biology.2021; 10(10): 985.     CrossRef
  • Characterization of the Immune Cell Infiltration Landscape of Thyroid Cancer for Improved Immunotherapy
    Jing Gong, Bo Jin, Liang Shang, Ning Liu
    Frontiers in Molecular Biosciences.2021;[Epub]     CrossRef
  • The Thyroid Tumor Microenvironment: Potential Targets for Therapeutic Intervention and Prognostication
    Laura MacDonald, Jonathan Jenkins, Grace Purvis, Joshua Lee, Aime T. Franco
    Hormones and Cancer.2020; 11(5-6): 205.     CrossRef
  • Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis
    Veronica Veschi, Francesco Verona, Melania Lo Iacono, Caterina D'Accardo, Gaetana Porcelli, Alice Turdo, Miriam Gaggianesi, Stefano Forte, Dario Giuffrida, Lorenzo Memeo, Matilde Todaro
    Frontiers in Endocrinology.2020;[Epub]     CrossRef
  • The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition
    Gilda Varricchi, Stefania Loffredo, Giancarlo Marone, Luca Modestino, Poupak Fallahi, Silvia Martina Ferrari, Amato de Paulis, Alessandro Antonelli, Maria Rosaria Galdiero
    International Journal of Molecular Sciences.2019; 20(16): 3934.     CrossRef
  • Impact of tumor‐associated macrophages and BRAFV600E mutation on clinical outcomes in patients with various thyroid cancers
    Jae Won Cho, Won Woong Kim, Yu‐mi Lee, Min Ji Jeon, Won Gu Kim, Dong Eun Song, Yangsoon Park, Ki‐Wook Chung, Suck Joon Hong, Tae‐Yon Sung
    Head & Neck.2019; 41(3): 686.     CrossRef
  • Senescent thyrocytes and thyroid tumor cells induce M2-like macrophage polarization of human monocytes via a PGE2-dependent mechanism
    Mara Mazzoni, Giuseppe Mauro, Marco Erreni, Paola Romeo, Emanuela Minna, Maria Grazia Vizioli, Cristina Belgiovine, Maria Grazia Rizzetti, Sonia Pagliardini, Roberta Avigni, Maria Chiara Anania, Paola Allavena, Maria Grazia Borrello, Angela Greco
    Journal of Experimental & Clinical Cancer Research.2019;[Epub]     CrossRef
  • Immune and Inflammatory Cells in Thyroid Cancer Microenvironment
    Silvia Martina Ferrari, Poupak Fallahi, Maria Rosaria Galdiero, Ilaria Ruffilli, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Armando Patrizio, Valeria Mazzi, Gilda Varricchi, Gianni Marone, Alessandro Antonelli
    International Journal of Molecular Sciences.2019; 20(18): 4413.     CrossRef
  • Aberrant Thyroid-Stimulating Hormone Receptor Signaling Increases VEGF-A and CXCL8 Secretion of Thyroid Cancer Cells, Contributing to Angiogenesis and Tumor Growth
    Young Shin Song, Min Joo Kim, Hyun Jin Sun, Hwan Hee Kim, Hyo Shik Shin, Young A. Kim, Byung-Chul Oh, Sun Wook Cho, Young Joo Park
    Clinical Cancer Research.2019; 25(1): 414.     CrossRef
  • The number of CD163 positive macrophages is associatedwith more advanced skin melanomas, microvessels density and patient prognosis
    Maciej Foks, Małgorzata Wągrowska-Danilewicz, Marian Danilewicz, Marta Bonczysta, Bogusław Olborski, Olga Stasikowska-Kanicka
    Polish Journal of Pathology.2019; 70(3): 217.     CrossRef
  • Novel targeted therapies and immunotherapy for advanced thyroid cancers
    George E. Naoum, Michael Morkos, Brian Kim, Waleed Arafat
    Molecular Cancer.2018;[Epub]     CrossRef
  • Potential involvement of neutrophils in human thyroid cancer
    Maria Rosaria Galdiero, Gilda Varricchi, Stefania Loffredo, Claudio Bellevicine, Tiziana Lansione, Anne Lise Ferrara, Raffaella Iannone, Sarah di Somma, Francesco Borriello, Eduardo Clery, Maria Triassi, Giancarlo Troncone, Gianni Marone, Fabrizio Mattei
    PLOS ONE.2018; 13(6): e0199740.     CrossRef
  • Bleomycin inhibits proliferation and induces apoptosis in TPC‑1 cells through reversing M2‑macrophages polarization
    Hongwei Liu, Huilei Dong, Li Jiang, Zhendong Li, Xiande Ma
    Oncology Letters.2018;[Epub]     CrossRef
  • Pathological processes and therapeutic advances in radioiodide refractory thyroid cancer
    Marika H Tesselaar, Johannes W Smit, James Nagarajah, Romana T Netea-Maier, Theo S Plantinga
    Journal of Molecular Endocrinology.2017; 59(4): R141.     CrossRef
  • Association of infiltrating cells with microvessel density in oral squamous cell carcinoma
    Olga Stasikowska-Kanicka, Małgorzata Wągrowska-Danilewicz, Marian Danilewicz
    Polish Journal of Pathology.2017; 68(1): 40.     CrossRef
  • Histological perspective on the effects of tumor-associated macrophages in the tumor microenvironment surrounding papillary thyroid carcinoma
    Nuray Y. Can, Semra Ayturk, Mehmet Celik, Yavuz A. Sezer, Filiz Ozyilmaz, Ebru Tastekin, Necdet Sut, Funda Ustun, Buket Yilmaz Bulbul, Fulya O. Puyan, Sibel Guldiken
    Polish Journal of Pathology.2017; 67(4): 332.     CrossRef
  • The immune network in thyroid cancer
    Maria Rosaria Galdiero, Gilda Varricchi, Gianni Marone
    OncoImmunology.2016; 5(6): e1168556.     CrossRef
  • Macrophage Densities Correlated with CXC Chemokine Receptor 4 Expression and Related with Poor Survival in Anaplastic Thyroid Cancer
    Dae In Kim, Eunyoung Kim, Young A Kim, Sun Wook Cho, Jung Ah Lim, Young Joo Park
    Endocrinology and Metabolism.2016; 31(3): 469.     CrossRef
  • CXCL16 signaling mediated macrophage effects on tumor invasion of papillary thyroid carcinoma
    Sun Wook Cho, Young A Kim, Hyun Jin Sun, Ye An Kim, Byung-Chul Oh, Ka Hee Yi, Do Joon Park, Young Joo Park
    Endocrine-Related Cancer.2016; 23(2): 113.     CrossRef
  • Role of pulmonary macrophages in initiation of lung metastasis in anaplastic thyroid cancer
    Xiu Juan Li, Prakash Gangadaran, Senthilkumar Kalimuthu, Ji Min Oh, Liya Zhu, Shin Young Jeong, Sang‐Woo Lee, Jaetae Lee, Byeong‐Cheol Ahn
    International Journal of Cancer.2016; 139(11): 2583.     CrossRef
  • The Expression and Relationship of CD68-Tumor-Associated Macrophages and Microvascular Density With the Prognosis of Patients With Laryngeal Squamous Cell Carcinoma
    Shujun Sun, Xinliang Pan, Limin Zhao, Jianming Zhou, Hongzeng Wang, Yonghong Sun
    Clinical and Experimental Otorhinolaryngology.2016; 9(3): 270.     CrossRef
  • Cancers with Higher Density of Tumor-Associated Macrophages Were Associated with Poor Survival Rates
    Kyong Yeun Jung, Sun Wook Cho, Young A Kim, Daein Kim, Byung-Chul Oh, Do Joon Park, Young Joo Park
    Journal of Pathology and Translational Medicine.2015; 49(4): 318.     CrossRef
  • Association of the Preoperative Neutrophil-to-ymphocyte Count Ratio and Platelet-to-Lymphocyte Count Ratio with Clinicopathological Characteristics in Patients with Papillary Thyroid Cancer
    Sang Mi Kim, Eun Heui Kim, Bo Hyun Kim, Jong Ho Kim, Su Bin Park, Yoon Jeong Nam, Kang Hee Ahn, Min Young Oh, Won Jin Kim, Yun Kyung Jeon, Sang Soo Kim, Yong Ki Kim, In Ju Kim
    Endocrinology and Metabolism.2015; 30(4): 494.     CrossRef
  • Quantitative Changes in Tumor-Associated M2 Macrophages Characterize Cholangiocarcinoma and their Association with Metastasis
    Malinee Thanee, Watcharin Loilome, Anchalee Techasen, Nisana Namwat, Thidarut Boonmars, Chawalit Pairojkul, Puangrat Yongvanit
    Asian Pacific Journal of Cancer Prevention.2015; 16(7): 3043.     CrossRef
  • Tumor-Associated Macrophage (TAM) and Angiogenesis in Human Colon Carcinoma
    Manal A. Badawi, Dalia M. Abouelfadl, Sonia L. El-Sharkawy, Wafaa E. Abd El-Aal, Naglaa F. Abbas
    Open Access Macedonian Journal of Medical Sciences.2015; 3(2): 209.     CrossRef
  • Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
    Won-Young Lee
    Endocrinology and Metabolism.2014; 29(3): 251.     CrossRef
  • miRNA Expression in Anaplastic Thyroid Carcinomas
    Aline Hébrant, Sébastien Floor, Manuel Saiselet, Aline Antoniou, Alice Desbuleux, Bérengère Snyers, Caroline La, Nicolas de Saint Aubain, Emmanuelle Leteurtre, Guy Andry, Carine Maenhaut, Raul M. Luque
    PLoS ONE.2014; 9(8): e103871.     CrossRef
  • The Expression of Tumor-Associated Macrophages in Papillary Thyroid Carcinoma
    Bo Hyun Kim
    Endocrinology and Metabolism.2013; 28(3): 178.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism
TOP